Literature DB >> 9829263

The hydrophobic moment plot and its efficacy in the prediction and classification of membrane interactive proteins and peptides.

D A Phoenix1, A Stanworth, F Harris.   

Abstract

The central premise of hydrophobic moment plot methodology is that primary sequence information alone may be used to differentiate between amphiphilic structures which are likely to belong to either surface active or globular proteins. However, the boundaries delineating the regions of the plot appear to be based on information derived from a relatively small protein data set and are not well defined. This, coupled with the uncertainties associated with interpretation of the significance of the hydrophobic moment has led the reliability of this methodology to be questioned with respect to predicting membrane interactions. Accordingly, we have used hydrophobic plot methodology to predict the cellular locations of an expanded set of proteins with known membrane location, including those of the original study. The accuracy of prediction was subjected to chi-square statistical analysis and here we discuss the conclusion that the predictive abilities of this methodology are no better than chance.

Mesh:

Substances:

Year:  1998        PMID: 9829263

Source DB:  PubMed          Journal:  Membr Cell Biol        ISSN: 1023-6597


  3 in total

1.  A statistical investigation of amphiphilic properties of C-terminally anchored peptidases.

Authors:  James Wallace; Frederick Harris; David A Phoenix
Journal:  Eur Biophys J       Date:  2003-04-30       Impact factor: 1.733

2.  Interaction of 18-residue peptides derived from amphipathic helical segments of globular proteins with model membranes.

Authors:  Chandrasekaran Sivakamasundari; Ramakrishnan Nagaraj
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

3.  Investigation of hydrophobic moment and hydrophobicity properties for transmembrane alpha-helices.

Authors:  James Wallace; Onkabetse A Daman; Frederick Harris; David A Phoenix
Journal:  Theor Biol Med Model       Date:  2004-08-16       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.